362 related articles for article (PubMed ID: 28359266)
1. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
2. New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis.
Barash U; Rangappa S; Mohan CD; Vishwanath D; Boyango I; Basappa B; Vlodavsky I; Rangappa KS
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34199150
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents.
Husain A; Rashid M; Shaharyar M; Siddiqui AA; Mishra R
Eur J Med Chem; 2013 Apr; 62():785-98. PubMed ID: 23333063
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
5. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety.
Zhao PL; Duan AN; Zou M; Yang HK; You WW; Wu SG
Bioorg Med Chem Lett; 2012 Jul; 22(13):4471-4. PubMed ID: 22647723
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
8. Efficient T3P
Kamath PR; Sunil D; Das S; Abdul Salam AA; Rao BS
Chem Biol Interact; 2017 Apr; 268():53-67. PubMed ID: 28235427
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
[TBL] [Abstract][Full Text] [Related]
10. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
[TBL] [Abstract][Full Text] [Related]
12. Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer Therapy.
Zubkova OV; Ahmed YA; Guimond SE; Noble SL; Miller JH; Alfred Smith RA; Nurcombe V; Tyler PC; Weissmann M; Vlodavsky I; Turnbull JE
ACS Chem Biol; 2018 Dec; 13(12):3236-3242. PubMed ID: 30480427
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety.
Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA
Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878
[TBL] [Abstract][Full Text] [Related]
14. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
[TBL] [Abstract][Full Text] [Related]
16. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
Lanzi C; Zaffaroni N; Cassinelli G
Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
[TBL] [Abstract][Full Text] [Related]
17. Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.
Madia VN; Messore A; Pescatori L; Saccoliti F; Tudino V; De Leo A; Bortolami M; Scipione L; Costi R; Rivara S; Scalvini L; Mor M; Ferrara FF; Pavoni E; Roscilli G; Cassinelli G; Milazzo FM; Battistuzzi G; Di Santo R; Giannini G
J Med Chem; 2018 Aug; 61(15):6918-6936. PubMed ID: 30010344
[TBL] [Abstract][Full Text] [Related]
18. Development of Novel Triazolo-Thiadiazoles from Heterogeneous "Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors.
Baburajeev CP; Dhananjaya Mohan C; Ananda H; Rangappa S; Fuchs JE; Jagadish S; Sivaraman Siveen K; Chinnathambi A; Ali Alharbi S; Zayed ME; Zhang J; Li F; Sethi G; Girish KS; Bender A; Basappa ; Rangappa KS
Sci Rep; 2015 Sep; 5():14195. PubMed ID: 26388336
[TBL] [Abstract][Full Text] [Related]
19. New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents.
Hamdy R; Jones AT; El-Sadek M; Hamoda AM; Shakartalla SB; Al Shareef ZM; Soliman SSM; Westwell AD
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830153
[TBL] [Abstract][Full Text] [Related]
20. Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.
Rondanin R; Fochi S; Baruchello R; Bernardi T; Oliva P; Semeraro F; Simoni D; Giannini G
Bioorg Med Chem Lett; 2017 Sep; 27(18):4421-4425. PubMed ID: 28811133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]